Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
This randomized phase II trial will compare the efficacy and toxicity of Gemcitabine plus Erlotinib versus Gemcitabine plus Erlotinib plus Oxaliplatin in patients with pancreatic cancer.
Inclusion criteria
- Pancreatic cancer